Advertisement

Topics

"Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma" Drugs and Medication Database

01:47 EST 22nd February 2019 | BioPortfolio

Here are the most relevant "Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma" Drugs and Medications that we have found in our database.

More Information about "Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma" on BioPortfolio

We have published hundreds of Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma news stories on BioPortfolio along with dozens of Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma Clinical Trials and PubMed Articles about Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma Companies in our database. You can also find out about relevant Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma Drugs and Medications on this site too.

Showing "Monoclonal Antibody Therapy Vaccine Therapy Treating Patients With" Drugs and Medications 1–25 of 93

Possibly Relevant

Zinplava [merck sharp & dohme corp.]

These highlights do not include all the information needed to use ZINPLAVA safely and effectively. See full prescribing information for ZINPLAVA. ZINPLAVA™ (bezlotoxumab) injection, for intravenous use Initial U.S. Approval: 2016

Campath [genzyme corporation]

These highlights do not include all the information needed to use CAMPATH safely and effectively. See full prescribing information for CAMPATH. CAMPATH (alemtuzumab) Injection for intravenous useInitial U.S. Approval: 2001

Aimovig [amgen inc]

These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018

Ajovy [teva pharmaceuticals usa, inc.]

These highlights do not include all the information needed to use AJOVY safely and effectively. See full prescribing information for AJOVY.AJOVY (fremanezumab-vfrm) injection, for subcutaneous useInitial U.S. Approval: 2018

Emgality [eli lilly and company]

These highlights do not include all the information needed to use EMGALITY safely and effectively. See full prescribing information for EMGALITY.EMGALITY (galcanezumab-gnlm) injection, for subcutaneous useInitial U.S. Approval: 2018

Vivotif-b [rebel distributors corp]

Vivotif-B

Engerix-b [dispensing solutions inc.]

ENGERIX-B Hepatitis B Vaccine (Recombinant)

Yervoy [e.r. squibb & sons, l.l.c.]

These highlights do not include all the information needed to use YERVOY safely and effectively. See full prescribing information for YERVOY. YERVOY (ipilimumab) injection, for intravenous useInitial U.S. Approval: 2011

Hepagam b [aptevo biotherapeutics llc]

These highlights do not include all the information needed to use HepaGam B safely and effectively. See full prescribing information for HepaGam B. HepaGam B [Hepatitis B Immune Globulin Intravenous (Human)], Sterile Solution for Intravenous or Intramuscu

Hepagam b [aptevo biotherapeutics llc]

These highlights do not include all the information needed to use HepaGam B safely and effectively. See full prescribing information for HepaGam B. HepaGam B [Hepatitis B Immune Globulin Intravenous (Human)], Sterile Solution for Intravenous or Intramuscu

Fasenra [astrazeneca pharmaceuticals lp]

These highlights do not include all the information needed to use FASENRA safely and effectively. See full prescribing information for FASENRA.FASENRA (benralizumab) injection, for subcutaneous useInitial U.S. Approval: 2017

Synagis [medimmune, llc]

These highlights do not include all the information needed to use SYNAGIS safely and effectively. See full prescribing information for SYNAGIS. SYNAGIS (palivizumab) injection, for intramuscular useInitial U.S. Approval: 1998

Sylvant [janssen biotech, inc.]

These highlights do not include all the information needed to use SYLVANT safely and effectively. See full prescribing information for SYLVANT. SYLVANT (siltuximab) for injection, for intravenous use Initial U.S. Approval: 2014

Nabi-hb [biotest pharmaceuticals corporation]

Hepatitis B Immune Globulin (Human) Nabi-HB Solvent Detergent Treated and Filtered

Repatha [amgen usa inc.]

These highlights do not include all the information needed to use REPATHA safely and effectively. See full prescribing information for REPATHA .     REPATHA (evolocumab) injection, for subcutaneous use Initial U.S. Approval: 2015

Repatha [amgen inc]

These highlights do not include all the information needed to use REPATHA safely and effectively. See full prescribing information for REPATHA .     REPATHA (evolocumab) injection, for subcutaneous use Initial U.S. Approval: 2015

Praxbind [boehringer ingelheim pharmaceuticals, inc.]

These highlights do not include all the information needed to use PRAXBIND safely and effectively. See full prescribing information for PRAXBIND. PRAXBIND (idarucizumab) injection, for intravenous useInitial U.S. Approval: 2015

Ocrevus [genentech, inc.]

These highlights do not include all the information needed to use OCREVUS safely and effectively. See full prescribing information for OCREVUS. OCREVUS (ocrelizumab) injection, for intravenous use Initial U.S. Approval: 2017

Tubersol [sanofi pasteur inc.]

Tuberculin Purified Protein Derivative(Mantoux)TUBERSOL

Tubersol [a-s medication solutions]

Tuberculin Purified Protein Derivative(Mantoux)TUBERSOL

Tubersol [a-s medication solutions]

Tuberculin Purified Protein Derivative(Mantoux)TUBERSOL

Takhzyro [dyax corp.]

These highlights do not include all the information needed to use TAKHZYRO™ safely and effectively. See full prescribing information for TAKHZYRO™. TAKHZYRO™ (lanadelumab-flyo) injection, for subcutaneous use.Initial U.S. Approval: 2018.

Tubersol [physicians total care, inc.]

Tuberculin Purified Protein Derivative(Mantoux)TUBERSOL

Ultomiris [alexion pharmaceuticals inc.]

These highlights do not include all the information needed to use ULTOMIRIS™ safely and effectively. See full prescribing information for ULTOMIRIS. ULTOMIRIS™ (ravulizumab-cwvz) injection, for intravenous useInitial U.S. Approval: 2018

Trogarzo [theratechnologies inc.]

These highlights do not include all the information needed to use TROGARZO safely and effectively. See full prescribing information for TROGARZO. TROGARZO™ (ibalizumab-uiyk) injection, for intravenous use Initial U.S. Approval: [2018]



Advertisement
Quick Search
Advertisement
Advertisement